Blog
Has Temu-Owner PDD's Story Changed After Double Miss?
Key Points
- Interested in PDD Holdings Inc. Sponsored ADR? Here are five stocks we like better.
- PDD is a huge player in Chinese e-commerce while also having a large non-Chinese presence through
These 3 Stocks Lowered Their Share Counts Drastically in Q1
Key Points
- Interested in Pinterest, Inc.? Here are five stocks we like better.
- Buyback authorizations are one thing, but companies actually executing on this potential spending is how
TH International Q1 Earnings Call Highlights
Key Points
- Interested in TH International Limited? Here are five stocks we like better.
- TH International reported weaker Q1 2026 results, with revenue down 14.6% year over year and same-store
Annexon Eyes ‘Win Season’ With Q4 Vision Trial Data, GBS Filings Ahead
Key Points
- Interested in Annexon, Inc.? Here are five stocks we like better.
- Annexon’s biggest near-term catalyst is fourth-quarter Phase III data for vonaprument in geographic atrophy, where
J. M. Smucker Q4 Earnings Call Highlights
Key Points
- Interested in The J. M. Smucker Company? Here are five stocks we like better.
- J. M. Smucker posted solid fourth-quarter results, with net sales up 6% and adjusted EPS rising 20% to
Cybersecurity Earnings: 1 AI Standout and 2 Stocks Under Pressure
Key Points
- Interested in Okta, Inc.? Here are five stocks we like better.
- Okta surged nearly 48% over two days after beating estimates and citing strong demand for its AI agent identity
AirJoule Technologies: A Cool Shot at a Multibagger
Key Points
- Interested in AirJoule Technologies Corporation? Here are five stocks we like better.
- AirJoule is on track to commercialize its technology, which is reflected in the stock's price.
Walmart's No. 2 Ranking Hides a Digital Transformation Story
Key Points
- Interested in Walmart Inc.? Here are five stocks we like better.
- Walmart Connect is becoming a major profit driver, with advertising revenue growing far faster than the company's core
Campbell's Soup Stock: Deep Value and a 7% Dividend Yield
Key Points
- Interested in The Campbell's Company? Here are five stocks we like better.
- Campbell's Soup Company is in position to rebound and enter price recovery as it transitions back to growth.
Caribou Biosciences Says CRISPR CAR-T Is Pivotal-Ready, CB-011 Data Nears
Key Points
- Interested in Caribou Biosciences, Inc.? Here are five stocks we like better.
- Vispa-cel, Caribou’s off-the-shelf CRISPR CAR-T for lymphoma, is now “pivotal-ready,” and the company
Oxford Instruments H2 Earnings Call Highlights
Key Points
- Interested in Oxford Instruments plc? Here are five stocks we like better.
- Oxford Instruments said full-year results came in slightly ahead of expectations, with second-half order
Corbus Pharmaceuticals Teases Cancer, Obesity Data as Key Clinical Readouts Near
Key Points
- Interested in Corbus Pharmaceuticals Holdings, Inc.? Here are five stocks we like better.
- Corbus Pharmaceuticals highlighted encouraging Phase 1 data for CRB-701 in cervical and
Hemab Therapeutics Details Post-IPO Pipeline Push, Sutacimig Phase III Plans
Key Points
- Interested in Hemab Therapeutics Holdings, Inc.? Here are five stocks we like better.
- Hemab Therapeutics said its lead drug sutacimig is on track to enter a pivotal Phase III trial
Zepp Health Q1 Earnings Call Highlights
Key Points
- Interested in Zepp Health Corporation Sponsored ADR? Here are five stocks we like better.
- Zepp Health posted a strong Q1, with total revenue rising 33.8% year over year to $51.5
CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans
Key Points
- Interested in CareDx, Inc.? Here are five stocks we like better.
- CareDx is pivoting deeper into precision diagnostics by divesting its lab products unit and using the proceeds to
Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls
Key Points
- Interested in Bioventus Inc.? Here are five stocks we like better.
- Bioventus said its financial profile has improved materially, with EBITDA margins rising above 20% in 2025, free
Vail Resorts Q3 Earnings Call Highlights
Key Points
- Interested in Vail Resorts, Inc.? Here are five stocks we like better.
- Severe weather across the Western U.S., especially in the Rockies, hurt Vail Resorts’ fiscal third-quarter
Gloo Q1 Earnings Call Highlights
Key Points
- Interested in Gloo Holdings? Here are five stocks we like better.
- Gloo beat Q1 expectations with revenue of $41.5 million, up 238% year over year, and adjusted EBITDA loss of $11.5
Mama's Creations Q1 Earnings Call Highlights
Key Points
- Interested in Mama's Creations, Inc.? Here are five stocks we like better.
- Mama's Creations posted a strong Q1 fiscal 2027, with revenue up 49.7% to $52.8 million, net income up
Mission Produce Q2 Earnings Call Highlights
Key Points
- Interested in Mission Produce, Inc.? Here are five stocks we like better.
- Mission Produce’s fiscal Q2 was hit by a severe avocado oversupply, especially from Mexico, which pushed
Motorcar Parts of America Q4 Earnings Call Highlights
Key Points
- Interested in Motorcar Parts of America, Inc.? Here are five stocks we like better.
- Motorcar Parts of America posted a strong fiscal fourth quarter, with net sales up 9.9% and gross
Amprius Insiders Are Selling: Should Investors Be Worried?
Key Points
- Interested in Amprius Technologies, Inc.? Here are five stocks we like better.
- Broad-based insider selling by Amprius Technologies executives creates a price headwind, though the stock
3 Stocks With Fresh Catalysts to Watch Before the July 4
Key Points
- Interested in Broadcom Inc.? Here are five stocks we like better.
- Broadcom's post-earnings selloff followed record revenue of $22.2 billion and 143% AI chip growth, creating a
A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
Key Points
- Interested in Nucor Corporation? Here are five stocks we like better.
- A weaker U.S. dollar can boost reported earnings for companies with significant international revenue by improving
Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead
Key Points
- Interested in Assembly Biosciences, Inc.? Here are five stocks we like better.
- Assembly Biosciences highlighted a key upcoming decision on its HSV-2 program with Gilead, including